Back to search

Article

Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland

2022-03-07

Abstract excerpt

Long-acting injectable antipsychotics (LAIs) offer many benefits to patients with schizophrenia spectrum disorder (SSD). They are used with very different frequencies due to questions of eligibility or patients’ and prescribers’ attitudes towards LAI use. We assessed the prescribing rates of LAIs in a large academic psychiatric hospital with public service mandate in Switzerland and compared them with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
76adb9bb-258d-52ad-ae1c-891d5342c25d
DOI
10.20944/preprints202203.0099.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in SwitzerlandDOI 10.20944/preprints202203.0099.v1
Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable AntipsychoticsSemantic proximity
Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm studySemantic proximity
Prescribing trends for the same patients with schizophrenia over 20 yearsSemantic proximity
“The Efficacy and Safety of Aripiprazole and Paliperidone 1 and 3-Month Long-Acting Preparations During The Maintenance of Schizophrenia in Clinical Practice”Semantic proximity
Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisationSemantic proximity
Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness studySemantic proximity
Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recoverySemantic proximity
Links between the amount of antipsychotic medication prescribed per population at general practice level, local demographic factors and medication selectionSemantic proximity
Assessing demographic and clinical characteristics and healthcare resource utilization of patients with schizophrenia with inadequate response to antipsychotic treatmentSemantic proximity
“Chill Packs” Self-Administered Olanzapine as Psychiatric Harm Reduction for Methamphetamine-Induced Psychosis: A Narrative Review of the Existing Evidence BaseSemantic proximity
Long-term Safety and Effectiveness of Lurasidone in Adolescents and Young Adults with Schizophrenia: Pooled Post hoc Analyses of Two 12-month Extension StudiesSemantic proximity
Antipsychotic management in general practice: serial cross-sectional study (2011-2020)Semantic proximity
Select a neighboring publication to make it the new centre.